|
|
Volumn 34, Issue 3, 2002, Pages 946-947
|
|
Cytomegalovirus matching does not predict symptomatic disease in intestinal transplantation
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYTOMEGALOVIRUS ANTIBODY;
GANCICLOVIR;
INTERLEUKIN 2 RECEPTOR ANTIBODY;
OKT 3;
RAPAMYCIN;
STEROID;
TACROLIMUS;
VIRUS ANTIGEN;
VIRUS DNA;
ADULT;
ANTIGEN DETECTION;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DNA HYBRIDIZATION;
ENDOSCOPIC BIOPSY;
EVALUATION;
GRAFT REJECTION;
GRAFT SURVIVAL;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INTESTINE TRANSPLANTATION;
MEDICAL RECORD;
ORGAN DONOR;
PREDICTION;
PRIORITY JOURNAL;
PROPHYLAXIS;
RECIPIENT;
RISK ASSESSMENT;
SEROLOGY;
SURVIVAL;
SYMPTOM;
ADOLESCENT;
ADULT;
ANTIBODIES, VIRAL;
CHILD;
CHILD, PRESCHOOL;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
DNA, VIRAL;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INFANT;
INTESTINES;
MIDDLE AGED;
POLYMERASE CHAIN REACTION;
POSTOPERATIVE COMPLICATIONS;
PREDICTIVE VALUE OF TESTS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0036262507
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02709-4 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (5)
|
